Many factors play a role in the troubling disparity in endometrial cancer, including poorer access to health care in some communities, a lack of awareness among some providers, and research efforts that often have not included enough people who are Black, Hispanic, and Asian, says Carol Brown, a gynecologic oncology surgeon and the Chief Health Equity Officer at Memorial Sloan Kettering Cancer Center in New York.
Research also suggests another important factor may be a cruel twist of biology. Black women are more often diagnosed with rare but aggressive forms of endometrial cancer that are not as well targeted by current treatments. This may also explain some of the disparity in survival rates between Black and White patients.”
See “Why Black Women Are Twice as Likely to Die of Endometrial Cancer — and What MSK Is Doing to Change It” on the Memorial Sloan Kettering Cancer Center website (October 1, 2021)